Authors


MD Magazine

Latest:

Historic Phase 3 Microbiota Trial for C Diff Treatment Completes Enrollment

RBX2660 from Rebiotix will be assessed in a randomized study involving 300 patients.



Tasneem Z. Naqvi, MD1

Latest:

Iatrogenic dilated cardiomyopathy and spectrum of current treatment modalities

Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).


Kristin Gerson, MD

Latest:

Updated Recommendations for Gestational Diabetes Streamline Screening Methods

In response to the growing prevalence of gestational diabetes mellitus and its associated morbidities, much attention has been paid to the use of appropriate screening methodologies for the metabolic disorder.






Alan H. Kadish, MD

Latest:

Nonischemic cardiomyopathy and implantable cardioverter-defibrillators

We assessed whether duration of nonischemic cardiomyopathy was related to the degree of benefit from implantable cardioverter-defibrillator (ICD) insertion. Subjects who had a recent diagnosis of nonischemic cardiomyopathy had at least a similar benefit from ICD insertion as did those with a remote diagnosis. These results indicate that ICD therapy should be considered in such patients as soon as they are diagnosed and once reversible causes of left ventricular dysfunction have been excluded.




Andrea Roalfe, MSc on behalf of the BAFTA Investigators: From Primary Care Clinical Sciences, University of Birmingham, Birmingham, Unite

Latest:

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?

We recruited 973 patients (mean age, 81 years) with atrial fibrillation from the primary care setting and randomly assigned them to receive anticoagulation with warfarin or aspirin.


Stephanie Ogozaly

Latest:

Psychological Factors May Explain Treatment Gaps for Patients with Depression

Conflicts between identity and depressive symptoms may account for the significant delays in help-seeking by patients with depression, according to research published October 2, 2012 in BMC Psychiatry.


Kathleen L. Wyne, MD, PhD, is an assistant professor, Division of Endocrinology

Latest:

The time has come for ethnicity-specific CV risk calculators

The risk calculator reported in the Lee et al paper was developed to predict the 10-year cardiovascular (CV) disease probability in an American Indian population.


Jon Stone

Latest:

Opioids Not a Good Idea for Lower Back Pain

Adding opioids or skeletal muscle relaxants to traditional nonsteroidal anti-inflammatory drug (NSAID) treatment for acute lower back pain (LBP) provides little improvement in pain management,



CAPT Valerie Riege, MSC, Chief Innovation

Latest:

Navy Medicine: A Strategic Roadmap for Implementing a Virtual Mental Health Program

A military service member talks about some of the ways the Navy is implementing new programs to improve mental health conditions.


Mushabbar A. Syed, MD

Latest:

Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HF with Preserved EF

Is degree of diffuse myocardial fibrosis associated with severity of diastolic dysfunction in heart failure with preserved ejection fraction?





Tasneem Z. Naqvi, MD is professor of clinical medicine, Division of Cardiovascular Medicine, Keck School of Medicine of USC, Los Angeles, California.

Latest:

Choice of imaging modality for evaluation of myocardial ischemia—what is the bottom line?

In Jahnke et al's study, the authors showed the prognostic value of yet another imaging modality—perfusion magnetic resonance (MR) imaging and dobutamine stress MR.


Nazanin Zafaranloo, MD

Latest:

Early statin therapy in acute coronary syndrome

Patients who survive an acute coronary syndrome are at much higher risk of a recurrent event within the following month than patients with stable coronary syndromes. Statin therapy lowers the risk of recurrent events for many years but also reduces the risk of another event within the weeks to months following the initial acute coronary syndrome. The mechanisms that contribute to this benefit are likely related to improved endothelial function, decreased vascular inflammation, and reduced prothrombotic factors. Observation studies show an early reduction in mortality with statin therapy started before discharge from the hospital after an acute coronary syndrome.


Jörg A. Walter, PhD

Latest:

Undiagnosed diabetes mellitus in coronary artery bypass graft surgery

We examined the prevalence and risks associated with undiagnosed diabetes mellitus among more than 7000 patients who had undergone coronary artery bypass graft surgery. At the perioperative and postoperative stages, patients with undiagnosed diabetes showed a significantly higher morbidity and mortality rate.


Anita Ramsetty

Latest:

Give the Old Guys a Chance: Remembering Older Insulins

I have not had a recent referred patient come to me on any older insulins. The big surprise? Many times I switch them back from Aspart, Levemir, and lantus.


Fadi El Baba, MD, Associate Professor, Department of Ophthalmology, SUNY at Stony Brook, New York.

Latest:

HMG-CoA reductase inhibitors and diabetic retinopathy

Increased serum lipid levels in diabetic pa­tients are associated with an increased risk of macular edema, retinal hard exudates, and secondary visual loss.


John Luo, MD

Latest:

Cutting the Cord: The Guide to Wireless Practice

Is a wireless practice right for you? If so, what components would benefit you most, and what should you know about them before making the jump?



Prachi Petal-Predd

Latest:

The Industry Insider: May 2007

News and information from the pharmaceutical industry. In this issue: 1) Multiple Deals for Affitech 2) Pfizer's Sutent Wins European Association of Urology Support 3) Aurora Breast MRI Will Meet Surge in Screening Demand 4) Two New Products for VioQuest 5) Cytyc and Quest Sign Multi-Year Agreement 6) Calando's Lead RNAi Candidate Shows Anti-Cancer Effect


© 2024 MJH Life Sciences

All rights reserved.